跳至主要内容
临床试验/NCT06045130
NCT06045130尚未招募不适用

Characteristics of PUFAs Composition in Preterm Infants and Its Impact on Disease Prognosis

The First Hospital of Jilin University0 个研究点目标入组 600 人开始时间: 2023年9月21日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
600
主要终点
Mortality and severe complications of premature infants

研究概览

简要总结

The research endeavors to examine the critical composition of Polyunsaturated Fatty Acids (PUFAs) in premature infants across different gestational stages and under varying disease conditions, and delineate the metabolic attributes of PUFAs in premature infants and their interplay with the onset of diseases. This study anticipates furnishing a theoretical foundation for the rationalization of PUFAs supplementation in premature infants and for informing strategies related to disease prevention and management.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Infants born between 24 and 36 weeks of gestational age who are admitted within 24 hours of birth, including both premature and full-term newborns.

排除标准

  • Infants with severe congenital developmental abnormalities, those requiring external supplementation of PUFAs in addition to standard intravenous nutrition and breastfeeding, and those with a severe prognosis indicating non-survival during their hospitalization.

结局指标

主要结局

Mortality and severe complications of premature infants

时间窗: before discharge

incidence of death,NEC,PDA,BPD,IVH,PVL and sepsis

次要结局

  • Mortality(before discharge)
  • PVL(before discharge)
  • NEC(before discharge)
  • PDA(before discharge)
  • BPD(before discharge)
  • IVH(before discharge)
  • sepsis(before discharge)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

PUFAs in Preterm Infants | 临床试验